Efficacy of Sodium Tetradecyl Sulphate  for the Treatment of Venous Malformation of The     Head and Neck

Komal Akram; Uzair Bin Akhtar; Shoaib Younus; Omer Sefvan Janjua; Rubbab Zahra; Sana Babar

doi:10.51253/pafmj.v74iSUPPL-2.9334

Authors

Komal Akram Department of Dentistry, Sharif Medical and Dental College, Lahore Pakistan
Uzair Bin Akhtar Department of Dentistry, Sharif Medical and Dental College, Lahore Pakistan
Shoaib Younus Institute of Dentistry, Combined Military Hospital Lahore/ National University of Medical Sciences (NUMS) Pakistan
Omer Sefvan Janjua Department of Dentistry, Faisalabad Medical University, Faisalabad Pakistan
Rubbab Zahra Department of Dentistry, Avicenna Medical and Dental College, Lahore Pakistan,
Sana Babar Department of Dentistry, Avicenna Medical and Dental College, Lahore Pakistan,

DOI:

https://doi.org/10.51253/pafmj.v74iSUPPL-2.9334

Keywords:

Head and Neck, Sclerotherapy, Venous malformations

Abstract

Objective: To assess the efficacy of Sodium Tetradecyl Sulphate for the treatment of venous malformations of the head and neck region.

Study Design: A prospective clinical study.

Place and Duration of Study: Oral and Maxillofacial Surgery department of Sharif Medical and Dental College Lahore, Pakistan from Apr 2021- Apr 2022.

Methodology: All the patients who met the inclusion criteria and were willing to take part in the study were enrolled. Pre-operative demographic data, clinical examination findings were noted in the specially designed proforma. The diagnosis was confirmed using doppler ultrasonography. 0.5-2ml of 3% STS was injected in the lesions transcutaneously or transmucosally depending on the location after aspiration and till blanching of the lesion occurred. Cases were followed up for 04 weeks and pre-op and post-op results were assessed independently by a consultant using the Achauer’s scale.

Results: Total 22 patients were enrolled. Mean age in the study was 17+11.93 years. Male to female ratio was 1:2.1. Buccal mucosa and the tongue were the most common sites, involved in 7(31.8%) cases. Complete and partial resolution was obtained in 14(63.6%) 22 cases. There were no post op complaints in majority of the patients. Post op pain, ulceration and sloughing was reported by 2(9.1%) of the patients.

Conclusion: The results of the study show that 3% STS was effective in reducing the size of the lesion to approximately 50% to the original size. Overall efficacy was found to be 63.6% with minimum morbidity and side effects.

Downloads

Download data is not yet available.

References

Colletti G, Valassina D, Bertossi D, Mel-chiorre F, Vercellio G, Brusati R. Contemporary management of vascular malformations. J Oral Maxillofac Surg 2014; 72: 510–28. http://dx.doi.org/10.1016/ j.joms.2013.08.008.

Fowell C, Verea Linares C, Jones R, Nishikawa H, Monaghan A. Venous malformations of the head and neck: current concepts in management. Br J Oral Maxillofac Surg 2017; 55: 3–9. doi: 10.1016/j.bjoms.2016.10.023.

Park H, Kim JS, Park H, Kim JY, Huh S, Lee JM, et al: Venous malformations of the head and neck: a retrospective review of 82 cases. Arch Plast Surg 2019; 46: 23-33. doi: 10.5999/aps.2018.00458.

Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163:269–74. doi: 10.1111/j.1365-2133.2010.09848.x.

Wang X, Meng J, Zhang J, Wu R, Gu J, Shao C, et al. Curative effects of RF combined with DSA-guided ethanol sclerotherapy in venous malformations. Exp Ther Med. 2016; 12: 3670-4. DOI: 10.3892/etm.2016.3804.

Morgan P, Keller R, Patel K. Evidence-based management of vascular malformations. Facial Plast Surg. 2016; 32: 162-76. DOI: 10.1055/s-0036-1581141.

Ali S, Weiss CR, Sinha A, Eng J, Mitchell SE. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center. Phlebology. 2016; 31: 603-9. doi: 10.1177/0268355516633380.

Heit JJ, Do HM, Prestigiacomo CJ, Delgado-Almandoz JA, English J, Gandhi CD, et al. Guidelines and parameters: percutaneous sclerotherapy for the treatment of head and neck venous and lymphatic malformations. J Neurointerv Surg. 2017; 9: 611-7. doi: 10.1136/neurintsurg-2015-012255.

Wohlgemuth WA, Muller-Wille R, Teusch V, Hammer S, Wildgruber M, Uller W. Ethanolgel sclerotherapy of venous malformations improves health-related quality-of-life in adults and children—results of a prospective study. Eur Radiol. 2017; 27: 2482-8. doi: 10.1007/s00330-016-4603-0.

Horbach SER, Lokhorst MM, Saeed P, de Gouyon Matignon de Pontouraude CMF, Rothova A, van der Horst CMA. Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg. 2016; 69: 295-304. http://dx.doi.org/10.1016/j.bjps.2015.10.045.

Kern P, Ramelet AA, Wutschert R, Mazzolai L. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins. Dermatol Surg. 2011; 37: 1590-4. doi: 10.1111/j.1524-4725.2011.02130.x.

Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg 1997; 99: 1301-8. doi: 10.1097/00006534-199704001-00014.

Ali S, Mitchell SE. Outcomes of venous malformation sclerotherapy: a review of study methodology and long-term results. Semin Intervent Radiol 2017; 34: 288-93. doi: 10.1055/s-0037-1604300.

Min HG, Kim SG, Oh JS, You JS. Sclerotherapy using 1% sodium tetradecyl sulfate to treat

a vascular malformation: a report of two cases. J Korean Assoc Oral Maxillofac Surg 2015; 41: 322-6. http://dx.doi.org/10.5125/jkaoms.2015.41.6.322.

Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27: 58–60.

Franca K, Ledon JS, Savas JS, Nouri K. Psychological Impact of Cutaneous Congenital Vascular Lesions. J Vasc Med Surg 2013; 1: 1 DOI: 10.4172/2329-6925.1000107.

Lokhorst MM, Horbach SER, Waner M, O TM, van der Vleuten CJM, Mokkink LB et al. Responsiveness of quality-of-life measures in patients with peripheral vascular malformations: the OVAMA project. Br J Dermatol 2020; 182: 1395-403. DOI 10.1111/bjd.18619.

Behravesh S, Yakes W, Gupta N, Naidu S, Chong BW, Khademhosseini A, et al. Venous malformations: clinical diagnosis and treatment. Cardiovasc Diagn Ther 2016; 6: 557-69. doi: 10.21037/cdt.2016.11.10.

De Maria L, De Santis P, Balakrishnan K, Tollefson M, Brinjikji W. Sclerotherapy for Venous Malformations of Head and Neck: Systematic Review and Meta-Analysis. Neurointervention 2020; 15: 4-17. https://doi.org/10.5469/neuroint.2019.00213.

Vollherbst DF, Gebhart P, Kargus S, Burger A, Kühle R, Günther P, et al. Image-guided percutaneous sclerotherapy of venous malformations of the head and neck: Clinical and MR-based volumetric mid-term outcome. PLoS One. 2020; 15(10): e0241347. DOI: 10.1371/journal.pone.0241347. PMID: 33119700; PMCID: PMC7595270.

De Maria L, De Sanctis P, Balakrishnan K, Tollefson M, Brinjikji W. Sclerotherapy for Venous Malformations of Head and Neck: Systematic Review and Meta-Analysis. Neurointervention. 2020; 15(1): 4-17. DOI: 10.5469/neuroint.2019.00213.

Alakailly X, Kummoona R, Quereshy FA, Baur DA, Gonzalez AE. J Maxillofac Oral Surg 2015; 14: 332-8. DOI 10.1007/s12663-014-0623-y.

Karimi E, Jafari M, Aghazadeh K, Sohranpour S, Tavakolnejad F. Treatment of Head and Neck Venous Malformations with Sodium Tetradecyl Sulfate. Am Academy Otorhinolryngol Head Neck Surg 2018. DOI: 10.1177/2473974X18797067.

Inbaraj A, Keshava SN, Moses V, Koshy G, Ahmed M, Mammen S et al. Sodium Tetradecyl Sulfate Sclerotherapy for Venous Malformation of the Tongue: A Single-Center Experience. J Clin Interv Radiol 2018;2: 76-82. DOI https://doi.org/10.1055/s-0038-1669372.

Zeevi I, Chaushu G, Alterman M, Chaushu L. Sclerotherapy of Vascular Malformations in the Oral Cavity-Minimizing Postoperative Morbidity. Medicina (Kaunas). 2020; 56(5): 254. DOI: 10.3390/medicina56050254. PMID: 32456057; PMCID: PMC7279465.